![Frontiers | Optimal Dose of Serotonin Reuptake Inhibitors for Obsessive-Compulsive Disorder in Adults: A Systematic Review and Dose–Response Meta-Analysis Frontiers | Optimal Dose of Serotonin Reuptake Inhibitors for Obsessive-Compulsive Disorder in Adults: A Systematic Review and Dose–Response Meta-Analysis](https://www.frontiersin.org/files/Articles/717999/fpsyt-12-717999-HTML/image_m/fpsyt-12-717999-t002.jpg)
Frontiers | Optimal Dose of Serotonin Reuptake Inhibitors for Obsessive-Compulsive Disorder in Adults: A Systematic Review and Dose–Response Meta-Analysis
![Frontiers | Optimal Dose of Serotonin Reuptake Inhibitors for Obsessive-Compulsive Disorder in Adults: A Systematic Review and Dose–Response Meta-Analysis Frontiers | Optimal Dose of Serotonin Reuptake Inhibitors for Obsessive-Compulsive Disorder in Adults: A Systematic Review and Dose–Response Meta-Analysis](https://www.frontiersin.org/files/Articles/717999/fpsyt-12-717999-HTML/image_m/fpsyt-12-717999-t001.jpg)
Frontiers | Optimal Dose of Serotonin Reuptake Inhibitors for Obsessive-Compulsive Disorder in Adults: A Systematic Review and Dose–Response Meta-Analysis
![Sertraline dosing trends in children and adolescents stratified by CYP2C19 genotype | Pharmacogenomics Sertraline dosing trends in children and adolescents stratified by CYP2C19 genotype | Pharmacogenomics](https://www.futuremedicine.com/cms/10.2217/pgs-2021-0135/asset/images/medium/figure2.gif)
Sertraline dosing trends in children and adolescents stratified by CYP2C19 genotype | Pharmacogenomics
![Serotonin Transporter Occupancy of Five Selective Serotonin Reuptake Inhibitors at Different Doses: An [11C]DASB Positron Emission Tomography Study | American Journal of Psychiatry Serotonin Transporter Occupancy of Five Selective Serotonin Reuptake Inhibitors at Different Doses: An [11C]DASB Positron Emission Tomography Study | American Journal of Psychiatry](https://ajp.psychiatryonline.org/cms/10.1176/appi.ajp.161.5.826/asset/images/medium/m88t1.jpeg)
Serotonin Transporter Occupancy of Five Selective Serotonin Reuptake Inhibitors at Different Doses: An [11C]DASB Positron Emission Tomography Study | American Journal of Psychiatry
![Sertraline Pharmacokinetics and Dynamics in Adolescents - Journal of the American Academy of Child & Adolescent Psychiatry Sertraline Pharmacokinetics and Dynamics in Adolescents - Journal of the American Academy of Child & Adolescent Psychiatry](https://www.jaacap.org/cms/attachment/7f652b5a-264c-4348-ad7c-1216ceb87156/gr1_lrg.gif)
Sertraline Pharmacokinetics and Dynamics in Adolescents - Journal of the American Academy of Child & Adolescent Psychiatry
![Early Improvement as a Predictor of Treatment Response in Patients With Obsessive-Compulsive Disorder: A 12-Week Randomized Trial of Sertraline and Fluvoxamine | Psychiatrist.com Early Improvement as a Predictor of Treatment Response in Patients With Obsessive-Compulsive Disorder: A 12-Week Randomized Trial of Sertraline and Fluvoxamine | Psychiatrist.com](https://www.psychiatrist.com/wp-content/uploads/2022/03/21m03065F1.gif)
Early Improvement as a Predictor of Treatment Response in Patients With Obsessive-Compulsive Disorder: A 12-Week Randomized Trial of Sertraline and Fluvoxamine | Psychiatrist.com
![Early Improvement as a Predictor of Treatment Response in Patients With Obsessive-Compulsive Disorder: A 12-Week Randomized Trial of Sertraline and Fluvoxamine | Psychiatrist.com Early Improvement as a Predictor of Treatment Response in Patients With Obsessive-Compulsive Disorder: A 12-Week Randomized Trial of Sertraline and Fluvoxamine | Psychiatrist.com](https://www.psychiatrist.com/wp-content/uploads/2022/03/21m03065T2.gif)
Early Improvement as a Predictor of Treatment Response in Patients With Obsessive-Compulsive Disorder: A 12-Week Randomized Trial of Sertraline and Fluvoxamine | Psychiatrist.com
![The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial - The Lancet Psychiatry The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial - The Lancet Psychiatry](https://www.thelancet.com/cms/attachment/79c3fdd6-6029-43cf-bf78-a9fa56502475/gr1_lrg.gif)
The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial - The Lancet Psychiatry
![Sertraline Pharmacokinetics and Dynamics in Adolescents - Journal of the American Academy of Child & Adolescent Psychiatry Sertraline Pharmacokinetics and Dynamics in Adolescents - Journal of the American Academy of Child & Adolescent Psychiatry](https://www.jaacap.org/cms/attachment/39af6a0e-41ac-45f9-9062-8c6150d43617/si1.gif)
Sertraline Pharmacokinetics and Dynamics in Adolescents - Journal of the American Academy of Child & Adolescent Psychiatry
![Improving Care and Collaboration for Children with Neurologic and Behavioral Conditions” Webinar #1 Depression January 25th, :00pm -2:00pm. - ppt download Improving Care and Collaboration for Children with Neurologic and Behavioral Conditions” Webinar #1 Depression January 25th, :00pm -2:00pm. - ppt download](https://slideplayer.com/slide/12642286/76/images/12/SSRI+Dosing+Chart+Medication+Starting+Dose+%28mg%2Fd%29+Increments+%28mg%29.jpg)